ClinicalTrials.gg

SmithKline Beecham clinical trials

Acquired by GlaxoSmithKline, Dec 27, 2000 · source ↗

The registry lists 3 studies whose lead sponsor is SmithKline Beecham. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 20, 2013.

Before and after it joined GlaxoSmithKline

First submitted before SmithKline Beecham became part of GlaxoSmithKline
3
First submitted after SmithKline Beecham became part of GlaxoSmithKline
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs SmithKline Beecham’s studies test, most studies first; none is open now — 4 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed267%
  • Status unknown or other133%

Phase

  • Phase 22
  • Phase 31

Where

  • United States2
  • United Kingdom1

Registry sponsor names on this page

  • SmithKline Beecham3 studies

Something wrong with this grouping? Tell us on the GlaxoSmithKline page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All GlaxoSmithKline studies →